Research ArticleCardiovascular
New Targets for Old Drugs: Cardiac Glycosides Inhibit Atrial-Specific K2P3.1 (TASK-1) Channels
Constanze Schmidt, Felix Wiedmann, Anne-Rike Gaubatz, Antonius Ratte, Hugo A. Katus and Dierk Thomas
Journal of Pharmacology and Experimental Therapeutics June 2018, 365 (3) 614-623; DOI: https://doi.org/10.1124/jpet.118.247692
Constanze Schmidt
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Felix Wiedmann
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Anne-Rike Gaubatz
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Antonius Ratte
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Hugo A. Katus
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Dierk Thomas
Department of Cardiology, Medical University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); Heidelberg Center for Heart Rhythm Disorders, University Hospital Heidelberg, Heidelberg, Germany (C.S., F.W., A.-R.G., A.R., H.A.K., D.T.); and German Centre for Cardiovascular Research, Heidelberg/Mannheim Partner Site, University of Heidelberg, Heidelberg, Germany (C.S., F.W., H.A.K., D.T.)
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCardiovascular
K2P3.1 Channel Block by Digoxin and Digitoxin
Constanze Schmidt, Felix Wiedmann, Anne-Rike Gaubatz, Antonius Ratte, Hugo A. Katus and Dierk Thomas
Journal of Pharmacology and Experimental Therapeutics June 1, 2018, 365 (3) 614-623; DOI: https://doi.org/10.1124/jpet.118.247692
Research ArticleCardiovascular
K2P3.1 Channel Block by Digoxin and Digitoxin
Constanze Schmidt, Felix Wiedmann, Anne-Rike Gaubatz, Antonius Ratte, Hugo A. Katus and Dierk Thomas
Journal of Pharmacology and Experimental Therapeutics June 1, 2018, 365 (3) 614-623; DOI: https://doi.org/10.1124/jpet.118.247692
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement